Tectonic Therapeutic (TECX) Change in Accured Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has reported Change in Accured Expenses for 10 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 147.79% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $4.5 million (up 143.08% YoY), while the FY2025 annual figure was -$552000.0, up 90.22% from the prior year.
• Change in Accured Expenses advanced to $1.6 million in Q1 2026 per TECX's latest filing, from $571000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $2.3 million in Q2 2023 and bottomed at -$3.4 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged -$403294.1 across 5 years, with a median of -$261000.0 in 2022.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 979.69% — and 2025, when it tumbled 347.25%.
• Tectonic Therapeutic's Change in Accured Expenses stood at -$2.6 million in 2022, then surged by 171.13% to $1.8 million in 2023, then slumped by 272.49% to -$3.2 million in 2024, then surged by 117.89% to $571000.0 in 2025, then soared by 185.99% to $1.6 million in 2026.
• Business Quant data shows TECX's Change in Accured Expenses at $1.6 million in Q1 2026, $571000.0 in Q4 2025, and $34000.0 in Q3 2025.